ViOptix Inc. With a foundation dating back to 1999, ViOptix is dedicated to delivering world-class technology to improve patient outcomes. Their clinically validated and FDA-cleared products have become the standard of care in many of America's top hospitals.

One of their flagship products is the T. Ox™, which measures tissue oxygen saturation in real time. They also offer the T.

Ox™ Remote, which provides clinicians with anytime, anywhere access to StO2 tissue oxygenation. Additionally, ViOptix has developed the Intra. Ox™, which measures tissue oxygen saturation during perfusion assessments in real time.

ViOptix has been recognized for its superior leadership, technological innovation, customer service, and strategic product development, receiving the prestigious Frost & Sullivan Best Practices Award. Headquartered in Newark, California, the brand is led by a distinguished team of executives, including Jack Lloyd as Executive Chairman, Scott E. Coleridge as CEO, Mark Lonsinger as Vice President and General Manager, and Melissa Liu as Controller.

With ViOptix, healthcare professionals can rely on cutting-edge technology to enhance patient care and achieve optimal outcomes